Melatonin controls several molecular signaling pathways, such as PI3/Akt/GSk3β and hemooxygenase-1 [39, 116, 117], and free radical scavenging mechanisms [118, 119] in the AD brain. This evidence concerns the gene AKT1 and Alzheimer disease.